Warning
F.H. INVESTMENTS Recalls Testosterone 100mg Anastrozole 4mg
This is a Class II recall. This product may cause temporary health problems or pose a slight threat of a serious nature.
Source: FDA
WarningRecall #D-0331-2026Drug / Pharmaceutical
F.H. INVESTMENTS Recalls Testosterone 100mg Anastrozole 4mg
F.H. INVESTMENTS, Inc. (dba Asteria Health) · Class II — Moderate Risk
Product Description
Testosterone 100mg Anastrozole 4mg , 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79559-4104-32
Reason for Recall
Presence of Foreign substance - potential presence of metal particulate matter
FDA Classification
Class II — Moderate Risk
A situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
Distribution
Nationwide in the USA
Remedy
Consumers should stop using this product. Contact the recalling firm for further instructions regarding this product.
411 Press Analysis
F.H. INVESTMENTS, Inc. (dba Asteria Health) has recalled a pharmaceutical product that the FDA classified as Class II affecting 1,464 pellets. The recall was initiated on January 26, 2026. Presence of Foreign substance - potential presence of metal particulate matter. It was distributed nationwide. Class II recalls involve products that might cause a temporary health problem or pose only a slight threat of a serious nature. Consumers should discontinue use and contact the firm.
Sources: FDA openFDA Enforcement Database
This recall appears in: Drug & Medical Product Contamination.